GlaxoSmithKline S.A.E (EGX:BIOC)

GlaxoSmithKline S.A.E Revenue

GlaxoSmithKline S.A.E had revenue of 958.94M EGP in the quarter ending June 30, 2026, with 7.63% growth. This brings the company's revenue in the last twelve months to 3.62B, up 2.80% year-over-year. In the year 2025, GlaxoSmithKline S.A.E had annual revenue of 3.73B with 24.73% growth.

• Revenue (ttm): 3.62B
• Revenue Growth: +2.80%
• P/S Ratio: 10.46
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 37.83B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.73B	739.68M	24.73%
Dec 31, 2024	2.99B	750.60M	33.51%
Dec 31, 2023	2.24B	416.99M	22.87%
Dec 31, 2022	1.82B	11.19M	0.62%
Dec 31, 2021	1.81B	-180.79M	-9.07%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error